Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.05 - Poster Session 1 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 25
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.05-005 - VEGF signaling inhibition by cediranib enhances the antitumor and anti-metastatic effects of radiation therapy more substantially than chemotherapy in orthotopic lung cancer models
09:30 - 09:30 | Author(s): O. Takahashi
- Abstract
Loading...
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-010 - Physical Targeting of Locally Advanced Non-Small Cell Lung Cancer (NSCLC): Proton Therapy
09:30 - 09:30 | Author(s): J.D. Cox
- Abstract
Loading...
-
+
P1.18 - Poster Session 1 - Pathology
- Type: Poster Session
- Track: Pathology
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.18-008 - Clinical impact of the two types of mucin in the mucinous adenocarcinoma of the lung - Clinical differences between the bronchogenic-type and the gastric-type mucinous adenocarcinomas
09:30 - 09:30 | Author(s): R. Kondo
- Abstract
Loading...
-
+
O02 - NSCLC - Combined Modality Therapy I
- Type: Oral Abstract Session
- Track: Combined Modality
- Presentations: 8
- Moderators:W.E.E. Eberhardt
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
-
+
O02.03 - Value of Adding Erlotinib to Thoracic Radiation Therapy with Chemotherapy for Stage III Non-Small Cell Lung Cancer: A Prospective Phase II Study
10:50 - 11:00 | Author(s): R. Komaki
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
O10 - Stereotactic Ablative Body Radiotherapy
- Type: Oral Abstract Session
- Track: Radiation Oncology + Radiotherapy
- Presentations: 8
- Moderators:H. Onishi
- Coordinates: 10/28/2013, 16:15 - 17:45, Parkside 110 A+B, Level 1
-
+
O10.02 - Radiation Therapy Oncology Group (RTOG) protocol 0915: A randomized phase II study comparing 2 Stereotactic Body Radiation Therapy (SBRT) schedules for medically inoperable patients (pts) with stage I peripheral Non-Small Cell Lung Cancer.
16:25 - 16:35 | Author(s): G. Videtic
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.10 - Poster Session 2 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.10-021 - The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harbouring mutations of the epidermal growth factor receptor.
09:30 - 09:30 | Author(s): R. Ko
- Abstract
Loading...
-
+
P2.19 - Poster Session 2 - Imaging
- Type: Poster Session
- Track: Imaging, Staging & Screening
- Presentations: 14
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.19-005 - Tumor growth rate of ground-glass nodules after long-term follow-up: The usefulness of a combination of initial computed tomography attenuation and tumor size as a predictor for tumor growth
09:30 - 09:30 | Author(s): T. Eguchi
- Abstract
Loading... -
+
P2.19-006 - Novel computed tomography windows for predicting pathological invasion area in pulmonary subsolid tumors
09:30 - 09:30 | Author(s): T. Eguchi
- Abstract
Loading...
-
+
MO13 - SCLC I
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 11
- Moderators:C.K. Liam
- Coordinates: 10/29/2013, 10:30 - 12:00, Bayside 201 - 203, Level 2
-
+
MO13.03 - Duration of Thoracic Radiotherapy with Concurrent Chemotherapy is Important for Outcome of Patients with Limited-Stage Small Cell Lung Cancer (L-SCLC)
10:40 - 10:45 | Author(s): R. Komaki
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO17 - Radiotherapy I: Stereotactic Ablative Body Radiotherapy
- Type: Mini Oral Abstract Session
- Track: Radiation Oncology + Radiotherapy
- Presentations: 12
- Moderators:M. Zwitter
- Coordinates: 10/29/2013, 16:15 - 17:45, Bayside 204 A+B, Level 2
-
+
MO17.11 - Stereotactic ablative radiotherapy (SABR) for centrally located early-stage or isolated parenchymal recurrences of non-small cell lung cancer (NSCLC): How to fly in a "no fly zone"
17:15 - 17:20 | Author(s): J.Y. Chang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
O27 - Clinical Trials and Practice
- Type: Oral Abstract Session
- Track: Other Topics
- Presentations: 8
- Moderators:J.S. Lee
- Coordinates: 10/29/2013, 16:15 - 17:45, Bayside Auditorium A, Level 1
-
+
O27.05 - Is primary tumor standardized uptake value (SUV) an independent prognostic factor for non-small cell lung cancer (NSCLC)? A meta-analysis based on individual patients data.
17:00 - 17:10 | Author(s): M. Paesmans
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
